Post-acute infectious syndrome (PAIS)
Clinical trials for Post-acute infectious syndrome (PAIS) explained in plain language.
Never miss a new study
Get alerted when new Post-acute infectious syndrome (PAIS) trials appear
Sign up with your email to follow new studies for Post-acute infectious syndrome (PAIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug reboot the immune system in chronic fatigue syndrome?
Disease control Not yet recruitingThis trial tests whether inebilizumab, an antibody that wipes out certain immune cells called B cells, can improve physical function in adults with ME/CFS that started after an infection. Participants receive three infusions over six months, and the study measures changes in mobi…
Matched conditions: POST-ACUTE INFECTIOUS SYNDROME (PAIS)
Phase 2 • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a Low-Dose antipsychotic ease long COVID brain fog?
Symptom relief Not yet recruitingThis study tests whether a low dose of aripiprazole, a drug used for psychiatric conditions, can reduce fatigue and improve thinking in adults with Long COVID or other post-infection syndromes. About 138 participants will receive either the drug or a placebo for 8 weeks, then swi…
Matched conditions: POST-ACUTE INFECTIOUS SYNDROME (PAIS)
Phase 2 • Sponsor: Christiana Franke • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC